Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2167-4825
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Imaging Features of Toxicities by Immune Checkpoint Inhibitors in Cancer Therapy ; volume:5 ; number:11 ; day:11 ; month:9 ; year:2017 ; pages:1-11 ; date:11.2017
Current radiology reports ; 5, Heft 11 (11.9.2017), 1-11, 11.2017
- Urheber
-
Widmann, Gerlig
- Beteiligte Personen und Organisationen
-
Nguyen, Van Anh
Plaickner, Julian
Jaschke, Werner
SpringerLink (Online service)
- DOI
-
10.1007/s40134-017-0256-2
- URN
-
urn:nbn:de:1111-2017121121223
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:32 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Widmann, Gerlig
- Nguyen, Van Anh
- Plaickner, Julian
- Jaschke, Werner
- SpringerLink (Online service)
Ähnliche Objekte (12)
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Gastrointestinal toxicities of proteasome inhibitor therapy
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy
Gastrointestinal toxicities of proteasome inhibitor therapy
Risk Factors for Immune Checkpoint Inhibitor–Mediated Cardiovascular Toxicities
Molecular fingerprints of cardiovascular toxicities of immune checkpoint inhibitors
Immune Checkpoint Inhibitor Rechallenge After Prior Immune Toxicity
Immune checkpoint inhibitor-related acral vasculitis
Cancer immunotherapy beyond immune checkpoint inhibitors
Thyroid disorders induced by immune checkpoint inhibitors
Kutane Nebenwirkungen unter Immun-Checkpoint-Inhibitor-Therapie
Immune Checkpoint Inhibitor Therapy in Neuroendocrine Tumors
Cardiotoxicity risk factors with immune checkpoint inhibitors
Immune checkpoint inhibitors for multiple myeloma immunotherapy
Neurotoxicities associated with immune checkpoint inhibitor therapy